Investigational Medicinial Product (IMP) - IM Woman Trial

A Contract Award Notice
by LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE

Source
Contracts Finder
Type
Contract (Products)
Duration
25 month
Value
£900K-£1M
Sector
HEALTH
Published
21 Aug 2023
Delivery
01 Aug 2023 to 31 Aug 2025
Deadline
05 Jan 2022 13:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023. A randomised, triple-blind, three-arm, non-inferiority trial to assess the efficacy and safety of intramuscular tranexamic acid compared to intravenous tranexamic acid and placebo in women having vvaginal and caesarean section births. Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution). Provision of treatment kit boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months commencing March 2023.

Award Detail

1 Sharp Clinical Services (Rhymney)
  • Value: £1,066,444

CPV Codes

  • 33141310 - Syringes
  • 33141320 - Medical needles
  • 33600000 - Pharmaceutical products
  • 33621000 - Medicinal products for the blood and blood-forming organs
  • 33621200 - Antihaemorrhagics
  • 33698000 - Clinical products
  • 39299100 - Glass ampoules
  • 44617100 - Cartons
  • 79920000 - Packaging and related services

Indicators

  • Contract is suitable for SMEs.

Other Information

Additional data https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=40736&B=LSHTM User / Company https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/104519

Reference

Domains